← All organizations

Excel Diagnostic Imaging Clinics

Academic/Hospital

Also known as: Excel Diagnostics Imaging Clinics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 1, 2009

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

in111-octreoscan

Other trials (1 own, 0 via acquisition)

fluorothymidine

Indications

Studied for

Neuroendocrine Tumors

Recent trials (2)

NCT00847509Overall official - principal investigatorN/AFeb 1, 2009
NCT00442533CollaboratorPhase 2/Phase 3Aug 1, 2005

Details

Last known activity: Feb 1, 2009